From professional translators, enterprises, web pages and freely available translation repositories.
hyperchloraemic acidosis
acidosi ipercloremica
Last Update: 2014-12-09
Usage Frequency: 20
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
hyperchloraemic acidosis.
acidosi ipercloremica (vedere paragrafo 4.2).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hyperchloraemic acidosis (see also 4.2).
acidosi ipercloremica (vedere paragrafo 4.2).
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
hyperchloraemic acidosis (see section 4.2).
acidosi ipercloremica (vedere paragrafo 4.2).
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
- if you have a condition called hyperchloraemic acidosis (too much acidity in your blood).
- se ha una condizione chiamata acidosi ipercloremica (troppa acidità nel sangue)
Last Update: 2012-04-12
Usage Frequency: 3
Quality:
if you have too much acidity in your blood ( a condition called hyperchloraemic acidosis) in babies and infants aged less than 2 years.
e ha troppa acidità nel sangue (condizione denominata acidosi ipercloremica) in neonati e bambini di età inferiore ai 2 anni.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
it should also not be used in patients with severe kidney disease or hyperchloraemic acidosis (excess acid in the blood caused by too much chloride).
inoltre, non deve essere utilizzato in pazienti affetti da insufficienza renale grave o da acidosi ipercloremica (eccesso di acido nel sangue causato dalla presenza eccessiva di cloruro).
Last Update: 2012-04-12
Usage Frequency: 3
Quality:
simbrinza has not been studied in patients with severe renal impairment (crcl < 30 ml/min) or in patients with hyperchloraemic acidosis.
simbrinza non è stato studiato in pazienti con grave compromissione renale (crcl < 30 ml/min) o in pazienti con acidosi ipercloremica.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
azopt has not been studied in patients with severe renal impairment (creatinine clearance < 30 ml/min) or in patients with hyperchloraemic acidosis.
azopt non è stato studiato in pazienti con compromissione renale grave (clearance della creatinina < 30 ml/min) o in pazienti con acidosi ipercloremica.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
azarga has not been studied in patients with severe renal impairment (creatinine clearance <30 ml/min) or in patients with hyperchloraemic acidosis (see section 4.3).
azarga non è stato studiato in pazienti con compromissione renale grave (clearance della creatinina <30 ml/min) o in pazienti con acidosi ipercloremica (vedere paragrafo 4.3).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting